Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|August 2, 2016
- Pharmaceutical Technology-08-02-2016
- Volume 40
- Issue 8
Portable Pumping System for Continuous Inline Mixing
The Ross SysCon Portable Pumping System is capable of handling laminar and turbulent flow applications across a 26-element low pressure drop static mixer.
The Ross SysCon Portable Pumping System with Static Mixer from Ross, Charles & Son is capable of handling laminar and turbulent flow applications across a 26-element low pressure drop static mixer. The system is ideal for continuous inline mixing of minor liquid components into a fluid stream. The mixer produces a homogenous blend, despite differences in the viscosity and density of the materials being pumped. The mobile skid includes a variable frequency drive for the feed pump, inlet, and outlet pressure transmitters, 4-inch color touchscreen for viewing process variables, emergency stop button, and a vortex enclosure cooler for the NEMA 4 Operator Station.
Articles in this issue
about 10 years ago
Designing Flexible Aseptic Containment Systemsabout 10 years ago
Using 3D Printing for Solid-Dosage Drugsabout 10 years ago
One Strategy for Updating an Aging Facilityabout 10 years ago
Downstream Processing Continues to Worry CMOsabout 10 years ago
Quality Manufacturing Key to Stemming Drug Shortagesabout 10 years ago
New Equipment Meets Need for Innovation in Pharma Manufacturingabout 10 years ago
Evaluating Technology and Innovation in Biopharmaceutical Manufacturingabout 10 years ago
FDA and the Emerging Technology of 3D Printingabout 10 years ago
Measuring Equipment and Manufacturing Trendsabout 10 years ago
Manufacturing and Distribution Boundaries BlurRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
2
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
3
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5